PMC:7161517 / 24319-25807
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T69 | 99-102 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T70 | 1055-1058 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
T71 | 1447-1450 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T111 | 15-23 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T112 | 196-199 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T113 | 257-265 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T114 | 267-279 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T115 | 310-318 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T116 | 323-330 | Disease | denotes | COVID19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T117 | 418-426 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T118 | 575-583 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T119 | 612-620 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T120 | 718-726 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T121 | 879-887 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T122 | 894-897 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T123 | 1007-1015 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T124 | 1112-1134 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T125 | 1139-1147 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T126 | 1245-1253 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T127 | 1347-1355 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T128 | 1479-1487 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T230 | 320-322 | http://purl.obolibrary.org/obo/CLO_0004265 | denotes | HT |
T231 | 510-517 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T232 | 1267-1272 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T233 | 1317-1318 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T275 | 99-102 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T276 | 178-191 | Chemical | denotes | ACE inhibitor | http://purl.obolibrary.org/obo/CHEBI_35457 |
T277 | 182-191 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T278 | 362-376 | Chemical | denotes | Angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719 |
T279 | 374-376 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T280 | 533-541 | Chemical | denotes | losartan | http://purl.obolibrary.org/obo/CHEBI_6541 |
T281 | 585-593 | Chemical | denotes | Losartan | http://purl.obolibrary.org/obo/CHEBI_6541 |
T282 | 691-699 | Chemical | denotes | Losartan | http://purl.obolibrary.org/obo/CHEBI_6541 |
T283 | 1055-1058 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T284 | 1059-1069 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T285 | 1273-1284 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
T286 | 1447-1450 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T287 | 1451-1461 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T66 | 123-133 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T151 | 0-134 | Sentence | denotes | With regard to COVID-19, there are currently several clinical studies investigating the effects of RAS inhibition and ACE2 regulation. |
T152 | 135-453 | Sentence | denotes | An ongoing study will assess the impact of ACE inhibitor and ARB treatment on the severity and prognosis of patients with COVID-19 (Hypertension in Patients Hospitalized With COVID-19 [HT-COVID19], NCT04318301; ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 [CODIV-ACE], NCT04318418). |
T153 | 454-771 | Sentence | denotes | Along these lines, there are 2 recently launched trials testing the effects of losartan among patients hospitalized with COVID-19 (Losartan for Patients With COVID-19 Requiring Hospitalization; NCT04312009) and those who are ambulatory (Losartan for Patients With COVID-19 Not Requiring Hospitalization; NCT04311177). |
T154 | 772-1148 | Sentence | denotes | Further studies have been launched to evaluate the effect of continuation versus replacement (Coronavirus [COVID-19] ACEi/ARB Investigation [CORONACION]; NCT04330300) or withdrawal (ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic [ACORES-2]; NCT04329195) of RAS inhibitors on the clinical outcomes in patients with cardiovascular disease and COVID-19. |
T155 | 1149-1370 | Sentence | denotes | There is also an ongoing pilot study assessing the effects of rhACE2 treatment in patients with COVID-19 (Recombinant Human Angiotensin-converting Enzyme 2 [rhACE2] as a Treatment for Patients With COVID-19; NCT04287686). |
T156 | 1371-1488 | Sentence | denotes | Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T39 | 267-279 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T40 | 1112-1134 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T802 | 15-23 | SP_7 | denotes | COVID-19 |
T803 | 118-122 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T804 | 123-133 | GO:0065007 | denotes | regulation |
T805 | 182-191 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T806 | 257-265 | SP_7 | denotes | COVID-19 |
T807 | 310-318 | SP_7 | denotes | COVID-19 |
T808 | 323-330 | SP_7 | denotes | COVID19 |
T809 | 362-376 | DG_37;PR:000036009 | denotes | Angiotensin II |
T810 | 418-426 | SP_7 | denotes | COVID-19 |
T811 | 533-541 | CHEBI:6541;CHEBI:6541 | denotes | losartan |
T812 | 575-583 | SP_7 | denotes | COVID-19 |
T813 | 612-620 | SP_7 | denotes | COVID-19 |
T814 | 679-689 | GO:0040011 | denotes | ambulatory |
T815 | 718-726 | SP_7 | denotes | COVID-19 |
T816 | 866-877 | NCBITaxon:11118 | denotes | Coronavirus |
T817 | 879-887 | SP_7 | denotes | COVID-19 |
T818 | 1007-1017 | SP_7 | denotes | SARS-CoV-2 |
T819 | 1059-1069 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T820 | 1112-1126 | UBERON:0004535 | denotes | cardiovascular |
T821 | 1139-1147 | SP_7 | denotes | COVID-19 |
T822 | 1245-1253 | SP_7 | denotes | COVID-19 |
T823 | 1267-1272 | SP_6;NCBITaxon:9606;PG_10 | denotes | Human |
T824 | 1273-1304 | PG_10;PR:000003622 | denotes | Angiotensin-converting Enzyme 2 |
T825 | 1347-1355 | SP_7 | denotes | COVID-19 |
T826 | 1451-1461 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T827 | 1479-1487 | SP_7 | denotes | COVID-19 |
T76836 | 17-25 | SP_7 | denotes | VID-19, |
T3029 | 163-174 | NCBITaxon:11118 | denotes | the impact |
T36086 | 176-184 | SP_7 | denotes | f ACE in |
T82622 | 304-314 | SP_7 | denotes | With COVI |
T40928 | 356-366 | CHEBI:35222;CHEBI:35222 | denotes | tors, Angi |
T14768 | 409-423 | UBERON:0004535 | denotes | erity of COVID |
T50691 | 436-444 | SP_7 | denotes | E], NCT0 |
T93421 | 541-549 | SP_7 | denotes | among p |
T67192 | 564-569 | SP_6;NCBITaxon:9606;PG_10 | denotes | lized |
T67994 | 570-601 | PG_10;PR:000003622 | denotes | with COVID-19 (Losartan for Pat |
T78338 | 645-653 | SP_7 | denotes | n; NCT04 |
T89352 | 750-760 | CHEBI:35222;CHEBI:35222 | denotes | zation; NC |
T71976 | 778-786 | SP_7 | denotes | r studie |
T44016 | 788-792 | G_3;PG_10;PR:000003622 | denotes | have |
T47722 | 797-807 | SP_7 | denotes | launched |
T88225 | 808-816 | SP_10 | denotes | o evalua |
T20549 | 869-879 | SP_7 | denotes | onavirus [ |
T74305 | 931-944 | NCBITaxon:11118 | denotes | 330300) or wi |
T20522 | 972-976 | G_3;PG_10;PR:000003622 | denotes | ARBs |
T10417 | 1082-1089 | NCBITaxon:10239 | denotes | cal out |
T82275 | 1172-1181 | SP_7 | denotes | g pilot s |
T54073 | 1191-1195 | G_3;PG_10;PR:000003622 | denotes | sing |
T59849 | 1257-1265 | SP_10 | denotes | combinan |
T87907 | 1272-1282 | SP_7 | denotes | Angiotens |
T87618 | 1292-1296 | G_3;PG_10;PR:000003622 | denotes | ing |
T56047 | 1335-1342 | GO:0009986 | denotes | tients |
T52387 | 1359-1368 | PG_1 | denotes | T04287686 |
T22150 | 1378-1382 | G_3;PG_10;PR:000003622 | denotes | ly, |
T49602 | 1402-1407 | NCBITaxon:10239 | denotes | suppo |
T68685 | 1468-1473 | NCBITaxon:10239 | denotes | ients |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1083 | 118-122 | Gene | denotes | ACE2 | Gene:59272 |
1084 | 178-181 | Gene | denotes | ACE | Gene:1636 |
1085 | 346-349 | Gene | denotes | ACE | Gene:1636 |
1086 | 362-376 | Gene | denotes | Angiotensin II | Gene:183 |
1087 | 434-437 | Gene | denotes | ACE | Gene:1636 |
1088 | 1273-1304 | Gene | denotes | Angiotensin-converting Enzyme 2 | Gene:59272 |
1089 | 954-957 | Gene | denotes | ACE | Gene:1636 |
1090 | 243-251 | Species | denotes | patients | Tax:9606 |
1091 | 283-291 | Species | denotes | Patients | Tax:9606 |
1092 | 548-556 | Species | denotes | patients | Tax:9606 |
1093 | 598-606 | Species | denotes | Patients | Tax:9606 |
1094 | 704-712 | Species | denotes | Patients | Tax:9606 |
1095 | 866-877 | Species | denotes | Coronavirus | Tax:11118 |
1096 | 1007-1017 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1097 | 1098-1106 | Species | denotes | patients | Tax:9606 |
1098 | 1231-1239 | Species | denotes | patients | Tax:9606 |
1099 | 1267-1272 | Species | denotes | Human | Tax:9606 |
1100 | 1333-1341 | Species | denotes | Patients | Tax:9606 |
1101 | 1465-1473 | Species | denotes | patients | Tax:9606 |
1102 | 533-541 | Chemical | denotes | losartan | MESH:D019808 |
1103 | 585-593 | Chemical | denotes | Losartan | MESH:D019808 |
1104 | 691-699 | Chemical | denotes | Losartan | MESH:D019808 |
1105 | 1211-1217 | Chemical | denotes | rhACE2 | |
1106 | 1306-1312 | Chemical | denotes | rhACE2 | |
1107 | 15-23 | Disease | denotes | COVID-19 | MESH:C000657245 |
1108 | 257-265 | Disease | denotes | COVID-19 | MESH:C000657245 |
1109 | 267-279 | Disease | denotes | Hypertension | MESH:D006973 |
1110 | 310-318 | Disease | denotes | COVID-19 | MESH:C000657245 |
1111 | 320-330 | Disease | denotes | HT-COVID19 | MESH:C000657245 |
1112 | 418-426 | Disease | denotes | COVID-19 | MESH:C000657245 |
1113 | 575-583 | Disease | denotes | COVID-19 | MESH:C000657245 |
1114 | 612-620 | Disease | denotes | COVID-19 | MESH:C000657245 |
1115 | 718-726 | Disease | denotes | COVID-19 | MESH:C000657245 |
1116 | 879-887 | Disease | denotes | COVID-19 | MESH:C000657245 |
1117 | 1112-1134 | Disease | denotes | cardiovascular disease | MESH:D002318 |
1118 | 1139-1147 | Disease | denotes | COVID-19 | MESH:C000657245 |
1119 | 1245-1253 | Disease | denotes | COVID-19 | MESH:C000657245 |
1120 | 1347-1355 | Disease | denotes | COVID-19 | MESH:C000657245 |
1121 | 1479-1487 | Disease | denotes | COVID-19 | MESH:C000657245 |